• JZL184: Monoacylglycerol Lipase Inhibitor for Advanced Neuro

  2026-05-15

  JZL184 is a benchmark monoacylglycerol lipase inhibitor enabling precise modulation of endocannabinoid signaling in neuronal and behavioral models. This guide integrates reference-backed insights and practical workflows to help researchers optimize JZL184 use for studying CB1-mediated pathways, pain, and cognitive dysfunction.

• Temozolomide: Mechanisms and Benchmarks in Glioma Research

  2026-05-14

  Temozolomide is a small-molecule alkylating agent widely used in DNA repair mechanism research and glioma models. It induces DNA damage via guanine methylation, enabling high-precision studies of chemotherapy resistance and cellular response. APExBIO’s Temozolomide (SKU B1399) offers reproducible, workflow-ready solutions for cancer model systems.

• Tioconazole: Mechanistic Depth and Assay Optimization in Ant

  2026-05-14

  Delve into the advanced antifungal mechanism of Tioconazole and discover how its molecular actions inform superior assay design in antifungal drug development. This article uniquely integrates insights from cancer metabolism research to elevate the application of Tioconazole as an antifungal medication in rigorous laboratory models.

• Sodium Orthovanadate for Phosphorylation State Preservation

  2026-05-13

  Sodium Orthovanadate (Na3VO4) is a gold-standard tool for preserving protein phosphorylation, enabling reproducible kinase assays and advanced metabolic research. Leveraging its competitive, reversible inhibition profile, laboratories can dissect cell signaling with precision while minimizing artifacts from phosphatase activity.

• Tβ4 Promotes Angiogenesis in Limb Ischemia via Notch/NF-κB M

  2026-05-13

  Lv et al. (2020) reveal that thymosin-β 4 (Tβ4) enhances angiogenesis in a mouse model of critical limb ischemia by upregulating angiogenic factors and modulating Notch/NF-κB pathways. Their use of the γ-secretase inhibitor DAPT (GSI-IX) provides mechanistic evidence for Notch signaling's role in vascular regeneration, informing future therapeutic strategies for ischemic disease.

• α-Amanitin for RNA Polymerase II Assays: Workflows & Solutio

  2026-05-12

  α-Amanitin enables unparalleled precision in dissecting RNA polymerase II-driven transcriptional regulation. This article details optimized workflows, advanced applications in gene expression analysis, and troubleshooting strategies to maximize data reliability in both developmental and disease model systems.

• Cefoperazone Sodium Salt: Resistance, Activity & Research Ut

  2026-05-12

  Cefoperazone sodium salt is a β-lactamase-stable, broad-spectrum semisynthetic cephalosporin antibiotic with potent activity against gram-negative bacilli and key gram-positive pathogens. Its stability, defined MIC/MBC values, and high biliary excretion support its use in in vitro and translational research. This article reviews its mechanism, evidence, and protocol integration for reliable antibacterial assays.

• Angiotensin III: Applied Workflows for RAAS and Viral Resear

  2026-05-11

  Unlock the full potential of Angiotensin III (Arg-Val-Tyr-Ile-His-Pro-Phe) in cardiovascular, neuroendocrine, and emerging virology research. This guide delivers hands-on protocols, cross-domain insights, and troubleshooting strategies for maximizing reproducibility and discovery using APExBIO's high-purity peptide.

• EGCG Nanoparticles Enhance FLASH-RT Efficacy via DNA Damage

  2026-05-11

  This study demonstrates that functionalized EGCG nanoparticles significantly improve the antitumor effects of ultra-high dose rate radiotherapy (FLASH-RT) by amplifying DNA damage and modulating immune responses. The findings support the potential of nanoparticle-based radiosensitizers for precision radiotherapy with improved safety.

• LY-411575: Gamma-Secretase Inhibitor for Precision Research

  2026-05-10

  LY-411575 from APExBIO empowers researchers to dissect gamma-secretase and Notch signaling with unparalleled precision in Alzheimer’s and cancer models. This article delivers actionable protocols, advanced troubleshooting, and key translational insights from recent breakthroughs in immuno-oncology.

• Biomimetic Chromatography for Pulmonary Drug Permeability Mo

  2026-05-09

  This study rigorously compares biomimetic open tubular capillary electrochromatography (OT-CEC) and immobilised artificial membrane chromatography (IAM-LC), both coupled to mass spectrometry, for modeling lung permeability of pharmaceuticals. The findings highlight the strengths, limitations, and practical potential of these MS-compatible approaches for high-throughput screening and permeability prediction in respiratory drug research.

• Itaconic Acid Feedback Inhibits TBK1-Driven Type I IFN Respo

  2026-05-09

  Chai et al. (2025) reveal that itaconic acid, produced by IRG1, suppresses excessive type I interferon (IFN-I) responses by alkylating TBK1 at Cys605, thereby preventing its dimerization and activation. This mechanistic insight provides a new metabolic checkpoint for immune regulation and introduces itaconic acid-based TBK1 inhibitors as potential therapies for IFN-I-mediated hyperinflammation.

• Gentamycin Sulfate: Decoding Resistance Mechanisms in CREC M

  2026-05-08

  Explore Gentamycin Sulfate’s role as a potent aminoglycoside antibiotic in decoding the molecular dynamics of resistance in carbapenem-resistant Enterobacter cloacae. This article offers a uniquely integrative perspective, bridging ribosomal inhibition, mobile genetic element transmission, and advanced assay guidance for translational researchers.

• Catalpol’s Neuroprotective Effects and Inflammation Modulati

  2026-05-07

  The referenced study comprehensively reviews catalpol, an iridoid glycoside from Rehmannia glutinosa, highlighting its neuroprotective, antioxidant, and anti-inflammatory mechanisms in Alzheimer’s disease (AD) models. The findings emphasize catalpol’s capacity to modulate neuroinflammation and apoptosis, suggesting its potential as a low-toxicity candidate for further AD therapy research.

• Resiniferatoxin (RTX): Protocols for Targeted TRPV1 Analgesi

  2026-05-07

  Resiniferatoxin (RTX) delivers ultra-potent, long-lasting desensitization of TRPV1-positive sensory neurons for advanced pain and inflammation models. This article details best-practice protocols, troubleshooting strategies, and translational insights from recent TRPV1 research, empowering reproducible and high-impact preclinical experiments.

450 records 18/30 page Previous Next First page 上5页 1617181920 下5页 Last page